News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Dec 1, 2022 8:00am EST

SCYNEXIS Announces FDA Approval of Second Indication for BREXAFEMME® (ibrexafungerp tablets) for Reduction in Incidence of Recurrent Vulvovaginal Candidiasis

Nov 30, 2022 8:30am EST

SCYNEXIS Announces $3 Million National Institutes of Health Grant Has Been Awarded to Case Western Reserve University Researchers to Study Second Generation Fungerp (SCY-247) to Fight Drug-Resistant Fungi

Latest Presentation

View All Presentations

Jan 9, 2023

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings